| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |